These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24552880)

  • 21. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database.
    Golden AG; Ma Q; Nair V; Florez HJ; Roos BA
    Ann Pharmacother; 2010 Sep; 44(9):1369-75. PubMed ID: 20606016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mephenesin: abuse and dependence.
    Prescrire Int; 2013 May; 22(138):127-8. PubMed ID: 23819177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical results with methocarbamol in opiate withdrawal.
    ZUCKER AH
    Am J Med Sci; 1959 Feb; 237(2):190-3. PubMed ID: 13626961
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study.
    de Abajo FJ; Gil MJ; García Poza P; Bryant V; Oliva B; Timoner J; García-Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1128-38. PubMed ID: 24692325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.
    Coelho C; Figueiredo R; Frank E; Burger J; Schecklmann M; Landgrebe M; Langguth B; Elgoyhen AB
    Audiol Neurootol; 2012; 17(3):179-88. PubMed ID: 22302057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mephenesin: Is There a Progression in Cases of Substance Use Related Disorders in France?
    Chevallier C; Batisse A; Fortias M; Djezzar S
    J Clin Psychopharmacol; 2018 Jun; 38(3):275-277. PubMed ID: 29620696
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiology of substance use and substance use disorders in Germany].
    Küfner H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Apr; 53(4):271-83. PubMed ID: 20232026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythema multiforme to tetrazepam.
    Cabrerizo Ballesteros S; Méndez Alcalde JD; Sánchez Alonso A
    J Investig Allergol Clin Immunol; 2007; 17(3):205-6. PubMed ID: 17583114
    [No Abstract]   [Full Text] [Related]  

  • 31. Abuse of combinations of carisoprodol and tramadol.
    Reeves RR; Liberto V
    South Med J; 2001 May; 94(5):512-4. PubMed ID: 11372804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of preoperative intravenous methocarbamol and intravenous acetaminophen on opioid use after primary total hip and knee replacement.
    Looke TD; Kluth CT
    Orthopedics; 2013 Feb; 36(2 Suppl):25-32. PubMed ID: 23379573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic baclofen abuse and withdrawal delirium.
    Nasti JJ; Brakoulias V
    Aust N Z J Psychiatry; 2011 Jan; 45(1):86-7. PubMed ID: 21058925
    [No Abstract]   [Full Text] [Related]  

  • 34. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient education and self-care for the management of jaw pain upon awakening: a randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine.
    Alencar FG; Viana PG; Zamperini C; Becker A
    J Oral Facial Pain Headache; 2014; 28(2):119-27. PubMed ID: 24822235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anorectal necrosis after paracetamol abuse.
    Streit E; Gholam P; Hadaschik E; Hartschuh W
    Br J Dermatol; 2014 Jan; 170(1):217-8. PubMed ID: 23957678
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of central muscle relaxants on single-dose pharmacokinetics of peroral paracetamol in man.
    Saano V; Elo HA; Paronen P
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):39-45. PubMed ID: 2303311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug abuse monitoring: which pharmacoepidemiological resources at the European level?
    Lapeyre-Mestre M; Dupui M
    Therapie; 2015; 70(2):147-65. PubMed ID: 25858571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs in dentistry. Muscle relaxants.
    Ciancio SG
    Dent Manage; 1985 Dec; 25(12):56, 59-60. PubMed ID: 3866707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.